| Literature DB >> 29721300 |
Travis L Calkins1, Mei-Er Chen1,2, Arinder K Arora1,3, Chloe Hawkings1, Cecilia Tamborindeguy1, Patricia V Pietrantonio1.
Abstract
Transcriptomes of dissected brains from virgin alate and dealate mated queens from polygyne fire ants (Solenopsis invicta) were analyzed and compared. Thirteen genes were upregulated in mated queen brain, and nine were downregulated. While many of the regulated genes were either uncharacterized or noncoding RNAs, those annotated genes included two hexamerin proteins, astakine neuropeptide, serine proteases, and serine protease inhibitors. We found that for select differentially expressed genes in the brain, changes in gene expression were most likely driven by the changes in physiological state (i.e., age, nutritional status, or dominance rank) or in social environment (released from influence of primer pheromone). This was concluded because virgins that dealated after being separated from mated queens showed similar patterns of gene expression in the brain as those of mated queens for hexamerin 1, astakine, and XR_850909. Abaecin (XR_850725), however, appears upregulated only after mating. Therefore, our findings contribute to distinguish how specific gene networks, especially those influenced by queen primer pheromone, are regulated in queen ants. Additionally, to identify brain signaling pathways, we mined the fire ant genome and compiled a list of G-protein-coupled receptors (GPCRs). The expression level of GPCRs and other genes in the "genetic toolkit" in the brains of virgin alates and mated dealate queens is reported.Entities:
Keywords: G‐protein‐coupled receptor; abaecin; astakine; hexamerin; juvenile hormone; reproductive maturation
Year: 2018 PMID: 29721300 PMCID: PMC5916306 DOI: 10.1002/ece3.3976
Source DB: PubMed Journal: Ecol Evol ISSN: 2045-7758 Impact factor: 2.912
Differentially expressed genes in brains of dealate mated versus alate virgin queens
| Gene ID | Gene name | Fold change | Total FPKM | Gene description | GO terms (from Ensembl Metazoa |
|---|---|---|---|---|---|
| XM_011157206 | LOC105192919 | −9 | 2,983.8 | Hexamerin‐like mRNA | |
| XM_011158637 | LOC105193944 | −3.04 | 171.45 | Facilitated trehalose transporter Tret1‐like, transcript variant X2, mRNA |
GO:0016020: membrane; GO:0016021: integral component of membrane; GO:0008643: carbohydrate transport; GO:0055085: transmembrane transport; |
| XM_011171175 | LOC105202586 | −3.14 | 159.87 | Uncharacterized LOC105202586, mRNA | GO:0004144: diacylglycerol O‐acyltransferase activity |
| XR_851183 | LOC105203692 | −4.42 | 138.31 | Uncharacterized LOC105203692 ncRNA | |
| XM_011174167 | LOC105204893 | −2.79 | 92.55 | Uncharacterized LOC105204893 partial mRNA | |
| XM_011160766 | LOC105195388 | −4.21 | 62.52 | Venom protease‐like partial mRNA | |
| XM_011161187 | LOC105195675 | −6.44 | 45.67 | UDP‐glucuronosyltransferase 2C1‐like, transcript variant X2, mRNA | GO:0008152: metabolic process; GO:0016758: transferase activity, transferring hexosyl groups |
| XM_011157651 | LOC105193270 | −10.89 | 24.36 | Chymotrypsin‐1‐like mRNA | GO:0006508: proteolysis; GO:0004252: serine‐type endopeptidase activity |
| XM_011157183 | LOC105192898 | −7.07 | 17.42 | Arylphorin subunit alpha‐like mRNA (hexamerin‐like) | |
| XR_850725 | LOC105195721 | 8.71 | 1,113.4 | Uncharacterized LOC105195721, ncRNA ( | |
| XR_850909 | LOC105199067 | 2.91 | 1,078.8 | Uncharacterized LOC105199067, ncRNA ( | |
| XM_011167747 | LOC105200273 | 3.63 | 617.96 | Chymotrypsin inhibitor‐like mRNA | |
| XM_011157536 | LOC105193179 | 6.48 | 408.9 | Endocuticle structural glycoprotein SgAbd‐1‐like mRNA | GO:0042302: structural constituent of cuticle |
| XM_011157405 | LOC105193076 | 2.75 | 256.88 | Uncharacterized LOC105193076, mRNA | |
| XM_011167741 | LOC105200265 | 2.79 | 233.08 | Astakine‐like mRNA | GO:0016021: integral component of membrane |
| XM_011167750 | LOC105200276 | 3.67 | 95.61 | Chymotrypsin inhibitor‐like mRNA | |
| XM_011165710 | LOC105198862 | 3.68 | 55.88 | Peptide‐methionine sulfoxide reductase, transcript variant X4, mRNA | GO:0055114: oxidation–reduction process; GO:0008113: peptide‐methionine (S)‐S‐oxide reductase activity |
| XM_011174636 | LOC105205292 | 3.21 | 33.77 | Uncharacterized LOC105205292, mRNA | GO:0006508: proteolysis; GO:0008237: metallopeptidase activity; GO:0008270: zinc ion binding |
| XM_011161436 | LOC105195830 | 2.48 | 30.88 | Uncharacterized LOC105195830 | GO:0006508: proteolysis; GO:0004222: metallo‐endopeptidase activity; GO:0008237: metallopeptidase activity |
| XM_011164314 | LOC105197777 | 3.98 | 30.72 | Phenoloxidase 2, mRNA | GO:0008152:metabolic process; GO:0016491: oxidoreductase activity |
| XM_011173486 | LOC105204417 | 4.5 | 22.67 | Membrane metallo‐endopeptidase‐like 1 mRNA | GO:0006508: proteolysis; GO:0007218: neuropeptide signaling pathway; GO:0004222: metallo‐endopeptidase activity; GO:0008237: metallopeptidase activity |
| XM_011157963 | LOC105193507 | 4.85 | 15.78 | Uncharacterized LOC105193507 |
q‐values for all differentially expressed genes <0.05.
Fold change indicates the relative change in expression in mated queen brains compared to virgin alate queens (negative values indicate lower expression in mated queens).
Fragments per kilobase of exon per million reads mapped.
NCBI Solenopsis invicta Genome Annotation Release 100 (https://metazoa.ensembl.org/index.html).
We previously cloned this cDNA and reported it as a putative glucose transporter 8 GenBank: AY911645.1 (Chen, Holmes, & Pietrantonio, 2006).
Blast analyses revealed that this predicted transcript appears to include the sequences of three contiguous aminopeptidases N.
Figure 1Verification of gene expression of four gene of interests found differentially expressed between mated versus alate queen brains in the transcriptome analysis. cDNA was synthesized from the same total RNA from the four replicates that were sequenced. Gene expression determined by qPCR was normalized to both elf1‐beta and rpl18. Bars represent mean log2 fold change ±SEM. “*” Indicates significant differences between virgin alate and mated queen brains determined by t test, p < .05, n = 4. Only hexamerin 1 gene was downregulated in dealate mated queen brain. p Values: hexamerin 1, .008; astakine, .009; nc725, .026; nc909, .017
Figure 2Validation of gene expression with independent samples of four gene of interests found differentially expressed in the transcriptome analysis between mated versus alate queen brains. cDNA was synthesized from independently collected queens. Gene expression determined by qPCR was normalized to both elf1‐beta and rpl18. Bars represent mean log2 fold change ±SEM. “*” Indicates significant differences between virgin alate and mated queen brains determined by t test, p < .05, n = 4. Hexamerin 1 expression was significantly reduced in mated queen brain. The relative trends in gene expression reflect transcriptome results. p Values: hexamerin 1, .019; astakine, .039; nc725, .057; nc909, .484
Figure 3Relative gene expression of the four gene of interests in brains of dealate newly mated (24‐hr postmating flight) queens versus alate virgin queens. Gene expression determined by qPCR was normalized to both elf1‐beta and rpl18. Bars represent mean log2 fold change ±SEM. “*” Indicates significant differences in gene expression between dealate newly mated versus alate virgin queens as determined by t tests, n = 4. p Values: hexamerin 1, <.001; astakine, .059; nc725, .007; nc909, .062
Number of virgin queens that remained alate or dealated after 48 hr of maintenance in queenless condition. Independent replicates (1–9), each composed of 12 virgin alates in queenless conditions, were set up. Contiguous cells separated by dashed lines correspond to queens which brains were pooled for qRT‐PCR analyses
| Replicates | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
|---|---|---|---|---|---|---|---|---|---|
| Alate virgin | 6 | 11 | 4 | 10 | 10 | 9 | 10 | 9 | 7 |
| Dealate virgin (% dealated) |
6 |
1 |
8 |
2 |
2 |
3 |
2 |
3 |
5 |
Figure 4Relative gene expression of four gene of interests in brains of queenright alate, queenless alate, and queenless dealate virgin queens. Gene expression determined by qPCR was normalized to both elf1‐beta and rpl18. Bars represent mean log2 fold change relative to queenright alates ±SEM, n = 4. Different letters indicate significant differences in gene expression as determined by one‐way ANOVA and Tukey's posthoc analyses (p < .05)
Figure 5Ovaries of virgin queens 5 days after the initiation of the alate separation assay. (a) Ovaries of virgin alates kept in queenright colonies are small and nonvitellogenic. (b) and (c) Virgins were kept for 5 days in queenless colonies. In (b), ovaries of virgins that did not dealate remained small, similar to those shown in (a) for queenright condition. In (c) virgins dealated within 48 hr of separation from the mated queen and developed vitellogenic ovaries (on the left of each ovary, a pair of forceps holding them is shown)
Figure 6Relative gene expression of hexamerin 1 in whole bodies of virgin queens treated with the juvenile hormone mimic S‐hydroprene under queenright conditions. Virgin queens dealated under queenright condition when treated with S‐hydroprene; none of the controls (untreated or acetone‐treated) were dealated. Gene expression in whole bodies determined by qPCR was normalized to both elf1‐beta and rpl18. Bars represent mean log2 fold change ±SEM with respect to the nontreated control, n = 3 with ten virgins each. “*” Indicates significant difference in gene expression between acetone‐treated control and S‐hydroprene‐treated queens as determined by t tests. Hexamerin 1 was significantly downregulated (p = .001)
G‐protein‐coupled receptors (GPCRs) expressed in queen brains above 10 FPKM. GPCRs are annotated as currently identified in the Solenopsis invicta genome and organized from highest to lowest FPKM. A complete list of expressed GPCRs in brains is shown in Table S3
| GeneInfo identifier | Protein accession | Transcript accession | Locus | Current annotation | Alate FPKM | Mated FPKM |
|---|---|---|---|---|---|---|
| gi|751222462| | XP_011164467.1 | XM_011166165 | LOC105199190 | Rhodopsin | 122.76 | 322.87 |
| gi|751202946| | XP_011174320.1 | XM_011176018 | LOC105206526 | Dopamine receptor 1 | 77.99 | 133.69 |
| gi|751222464| | XP_011164468.1 | XM_011166166 | LOC105199191 | Rhodopsin‐like | 91.27 | 77.23 |
| gi|751236330| | XP_011171996.1 | XM_011173694 | LOC105204568 | PDF receptor | 25.29 | 51.09 |
| gi|751222675| | XP_011164585.1 | XM_011166283 | LOC105199276 | Probable G‐protein‐coupled receptor AH9.1 | 28.82 | 35.67 |
| gi|751209716| | XP_011157518.1 | XM_011159216 | LOC105194339 | Probable G‐protein‐coupled receptor 52 | 25.64 | 34.81 |
| gi|751223066| | XP_011164802.1 | XM_011166501 | LOC105199400 | Muscarinic acetylcholine receptor DM1 isoform X1 | 23.83 | 28.15 |
| gi|751231202| | XP_011169146.1 | XM_011170844 | LOC105202369 | Metabotropic glutamate receptor | 25.85 | 24.04 |
| gi|751205599| | XP_011176389.1 | XM_011178087 | LOC105208274 | Tachykinin‐like peptide receptor 99D, partial | 17.37 | 32.48 |
| gi|751223401| | XP_011164985.1 | XM_011166683 | LOC105199537 | Opsin, ultraviolet‐sensitive‐like | 37.04 | 12.26 |
| gi|751238153| | XP_011173009.1 | XM_011174707 | LOC105205353 | Dopamine receptor 2‐like | 22.89 | 21.39 |
| gi|751212977| | XP_011159291.1 | XM_011160989 | LOC105195542 | G‐protein‐coupled receptor moody isoform X2 | 17.37 | 20.21 |
| gi|751212975| | XP_011159290.1 | XM_011160988 | LOC105195542 | G‐protein‐coupled receptor moody isoform X1 | 20.10 | 14.75 |
| gi|751220178| | XP_011163208.1 | XM_011164906 | LOC105198249 | Putative Golgi pH regulator C isoform X2 | 16.06 | 18.00 |
| gi|751232987| | XP_011170144.1 | XM_011171842 | LOC105203085 | Tachykinin‐like peptide receptor 99D | 12.70 | 18.85 |
| gi|751223068| | XP_011164803.1 | XM_011166500 | LOC105199400 | Muscarinic acetylcholine receptor DM1 isoform X2 | 14.03 | 11.49 |
| gi|751233286| | XP_011170315.1 | XM_011172013 | LOC105203239 | Allatostatin‐A receptor‐like isoform X1 | 13.64 | 11.55 |
| gi|751219449| | XP_011162809.1 | XM_011164507 | LOC105197902 | Calcitonin receptor‐like | 12.55 | 12.61 |
| gi|751210001| | XP_011157676.1 | XM_011159374 | LOC105194460 | Diuretic hormone receptor‐like | 13.13 | 11.57 |
| gi|751222422| | XP_011164446.1 | XM_011166144 | LOC105199174 | 5‐hydroxy‐tryptamine receptor 2A‐like isoform X1 | 14.54 | 10.06 |
| gi|751207421| | XP_011156273.1 | XM_011157971 | LOC105193512 | Tyramine receptor 1 | 9.84 | 12.28 |
| gi|751223477| | XP_011165026.1 | XM_011166724 | LOC105199572 | 5‐hydroxy‐tryptamine receptor 2B‐like | 6.77 | 14.55 |
| gi|751231536| | XP_011169333.1 | XM_011171031 | LOC105202476 | Octopamine receptor beta‐1R‐like | 12.93 | 6.29 |
| gi|751211218| | XP_011158340.1 | XM_011160038 | LOC105194900 | 5‐hydroxy‐tryptamine receptor 2A‐like | 7.82 | 10.80 |
PDF, pigment‐dispersing factor.
Social insects conserved genes expressed in queen brains implicated in signaling, and linking nutrition, growth, and/or division of labor
| Gene | Locus | Transcript accession | Protein accession | Alate FPKM | Mated FPKM |
|
|---|---|---|---|---|---|---|
| Vitellogenin‐2 | LOC105205782 | XM_011175285.1 | NP_001291513.1 | 5,154.83 | 8,001.340 | 0.999 |
| Vitellogenin‐3 | LOC105205783 | XM_011175286.1 | NP_001291514.1 | 141.528 | 6,092.370 | 0.999 |
| Vitellogenin‐1/4 (this includes both Vg1 and Vg4) | LOC105205865 | XM_011175398 | 237.681 | 272.394 | 0.999 | |
| Vitellogenin receptor | LOC105200757 | XM_011168460.1 | XP_011166762.1 | 18.282 | 0.41385 | 0.080 |
| Insulin receptor‐like (InR‐1) | LOC105207962 | XM_011177659.1 | XP_011175961.1 | 0.92114 | 1.01496 | 0.999 |
| Insulin‐like peptide receptor, transcript variant X2 | LOC105195102 | XM_011160339.1 | XP_011158641.1 | 3.2725 | 3.11185 | 0.999 |
| Insulin‐like peptide receptor, transcript variant X2 | LOC105195102 | XM_011160338.1 | NP_001291521.1 | 0.36031 | 0.22321 | 1.000 |
| sNPF receptor (annotation: prolactin‐releasing hormone receptor) | LOC105195500 | XM_011160926 | XP_011159228.1 | 1.74498 | 2.15420 | 0.999 |
| sNPF receptor (annotation: prolactin‐releasing hormone receptor) | LOC105195500 | XM_011160928 | XP_011159230.1 | 1.67119 | 0.00067 | 0.999 |
| sNPF receptor (annotation: prolactin‐releasing hormone receptor) | LOC105195500 | XM_011160929 | XP_011159231.1 | 0.676592 | 1.60495 | 0.999 |
| sNPF receptor (annotation: prolactin‐releasing hormone receptor) | LOC105195500 | XM_011160927 | XP_011159229.1 | 0.000374 | 1.41590 | 0.999 |
| sNPF peptide (sNPY) | LOC105194759 | XM_011159844.1 | XP_011158146.1 | 1.79674 | 0.00000 | 0.999 |
| sNPF peptide (sNPY) | LOC105194759 | XM_011159845.1 | XP_011158147.1 | 0.886964 | 0.00073 | 1.000 |
| sNPF peptide (sNPY) | LOC105194759 | XM_011159846.1 | 12.3637 | 13.43440 | 0.999 | |
| sNPF peptide (sNPY) | LOC105194759 | XM_011159847.1 | XP_011158149.1 | 22.429 | 31.67950 | 0.999 |
| Hexamerin 1 | LOC105192919 | XM_011157206 | XP_011155508.1 | 3,163.69 | 328.919 | 0.032 |
| Hexamerin 2 | LOC105204474 | XM_011173560 | XP_011171862.1 | 14.0452 | 3.80346 | 0.519 |
| Arylphorin‐alpha | LOC105192898 | XM_011157183 | XP_011155485.1 | 16.0248 | 5.75889 | 0.032 |
| Arylphorin‐beta | LOC105192897 | XM_011157182 | XP_011155484.1 | 1.04915 | 0.820838 | 0.998 |